Bookmarks
Critical need to restore community blood supply
Northfield Laboratories Inc announced that the US Food and Drug Administration (FDA) has accepted for filing its Biologics License Application (BLA) for PolyHeme, the company's investigative human haemoglobin-based red cell substitute for the treatment of life-threatening red blood cell loss when an oxygen-carrying fluid is required and red blood cells are not available.
Recently we have heard much about the beneficial effects associated with alcohol consumption, especially heart disease prevention. However, all alcohols are not made equal and red wine is by far the healthiest choice.
It might be possible to grow human blood platelets in the laboratory for transfusion, according to a new study at The Ohio State University Medical Center. The findings, published in the January 1, 2009 issue of the journal Experimental Hematology, might one day enable blood banks to grow platelets continuously and in quantities that can ease the chronically tight supply of these critical ...
As I was getting undressed for the shower I noticed blood in my knickers. It was bright red and there seemed to be quite alot. I rang the midwife and they advised me to come staright to the labour ward.
Those seeking to give the gift of life this holiday season will no longer have to wait for a mobile collection vehicle or drive downtown to donate blood, officials with Gulf Coast Regional Blood Center announced Monday.
Wilmington resident Kim Peddie has donated her red blood cells, plasma and platelets every 56 days since 1996.She knows the drill.Sign in, health check, needle in, needle out, done.Each appointment at Carolina Blood Services takes her about half an hour, Peddie said, and she considers it worth every minute.
The Red Cross asks you to help save lives by donating blood regularly
QFor the past 20 years, my type-A blood cells have been running 3.1 to 3.6, which I am told is low.
Northfield Laboratories, a developer of hemoglobin-based blood substitute product, has announced that the FDA has accepted for filing its biologics license application for PolyHeme, the companys investigative human hemoglobin-based red cell substitute for the treatment of life-threatening red blood cell loss when an oxygen-carrying fluid is required and red blood cells are not available.
© 2009 Blood Cord Bank